LEAP THERAPEUTICS INC (LPTX) Stock Analyst Earnings Estimates
NASDAQ:LPTX - Nasdaq - US52187K2006 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.5M | 1.5M | 1.224M -100.00% | 40.22M | 83.518M 107.65% | 123.06M 47.35% | 156.6M 27.25% | ||||||||
| EBITDA YoY % growth | -33.404M -8.80% | -28.505M 14.67% | -41.397M -45.23% | N/A -37.08% | N/A -1.23% | N/A -21.95% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.451M -8.78% | -28.539M 14.68% | -41.426M -45.16% | -56.986M -37.02% | -89.903M -1.23% | -70.03M -21.93% | -48.277M 31.09% | -40.066M 17.01% | -49.572M -23.73% | -57.963M -16.93% | -21.586M 62.76% | 6.066M 128.10% | 33.97M 460.01% | 56.048M 64.99% | |
| Operating Margin | N/A | -1,902.60% | -2,761.73% | -4,655.71% | N/A | N/A | N/A | N/A | N/A | N/A | -53.67% | 7.26% | 27.60% | 35.79% | |
| EPS YoY % growth | -1.50 -16.28% | -0.55 63.33% | -0.48 12.73% | -4.98 -879.17% | -4.18 -8.09% | -1.86 63.78% | -1.13 38.47% | -0.54 52.25% | -0.56 -3.77% | -0.64 -14.55% | -0.23 63.49% | 0.06 126.09% | 0.37 500.00% | 0.62 69.44% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 43.12% | -0.24 44.36% | -0.20 44.86% | -0.12 66.92% |
| Revenue Q2Q % growth | N/A | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.835M 39.61% | -10.498M 41.21% | -8.709M 45.99% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.37 27.45% | -0.39 | 0.02 | 4.54% |
| Q4 2024 Q2Q % growth | -0.37 19.57% | -0.37 | 0.00 | -0.76% |
| Q3 2024 Q2Q % growth | -0.44 13.73% | -0.49 | 0.05 | 10.13% |
| Q2 2024 Q2Q % growth | -0.52 42.86% | -0.44 | -0.08 | -18.56% |
| Q1 2024 Q2Q % growth | -0.51 84.06% | -0.60 | 0.09 | 14.53% |
| Q4 2023 Q2Q % growth | -0.46 54.00% | -0.56 | 0.10 | 18.00% |
| Q3 2023 Q2Q % growth | -0.51 60.77% | -0.59 | 0.08 | 13.49% |
| Q2 2023 Q2Q % growth | -0.91 39.33% | -0.91 | 0.00 | 0.43% |
| Q1 2023 Q2Q % growth | -3.20 -255.56% | -1.00 | -2.20 | -220.13% |
| Q4 2022 Q2Q % growth | -1.00 -900.00% | -1.12 | 0.12 | 10.87% |
| Q3 2022 Q2Q % growth | -1.30 -828.57% | -1.22 | -0.08 | -6.21% |
| Q2 2022 Q2Q % growth | -1.50 -1,150.00% | -0.98 | -0.52 | -53.19% |
| Q1 2022 Q2Q % growth | -0.90 -650.00% | -1.02 | 0.12 | 11.76% |
| Q4 2021 Q2Q % growth | -0.10 -11.11% | -0.11 | 0.01 | 10.87% |
| Q3 2021 Q2Q % growth | -0.14 -55.56% | -0.11 | -0.03 | -22.55% |
| Q2 2021 Q2Q % growth | -0.12 | -0.13 | 0.01 | 5.88% |
| Q1 2021 Q2Q % growth | -0.12 52.00% | -0.11 | -0.01 | -10.99% |
| Q4 2020 Q2Q % growth | -0.09 72.73% | -0.09 | 0.00 | -0.27% |
| Q3 2020 Q2Q % growth | -0.09 72.73% | -0.13 | 0.04 | 31.07% |
| Q2 2020 Q2Q % growth | -0.12 67.57% | -0.18 | 0.06 | 34.64% |
| Q1 2020 Q2Q % growth | -0.25 46.81% | -0.25 | 0.00 | -0.04% |
| Q4 2019 Q2Q % growth | -0.33 | -0.32 | -0.01 | -1.90% |
| Q3 2019 Q2Q % growth | -0.33 | -0.34 | 0.01 | 1.96% |
| Q2 2019 Q2Q % growth | -0.37 | -0.44 | 0.07 | 14.98% |
| Q1 2019 Q2Q % growth | -0.47 | -0.42 | -0.05 | -12.39% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -100.00% | 1.224M | -1.224M | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | 77.52K | -77.52K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 159.12K | -159.12K | -100.00% |
| Q4 2021 Q2Q % growth | 375K | 312.12K | 62.88K | 20.15% |
| Q3 2021 Q2Q % growth | 375K | 1.541M | -1.166M | -75.67% |
| Q2 2021 Q2Q % growth | 375K | 311.1K | 63.9K | 20.54% |
| Q1 2021 Q2Q % growth | 375K | 197.625K | 177.375K | 89.75% |
| Q4 2020 Q2Q % growth | 375K | 529.125K | -154.125K | -29.13% |
| Q3 2020 Q2Q % growth | 375K | 1.02M | -645K | -63.24% |
| Q2 2020 Q2Q % growth | 375K | 637.5K | -262.5K | -41.18% |
| Q1 2020 Q2Q % growth | 375K | 2.55M | -2.175M | -85.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 17.14% | 0% | 11.9% |
| Revenue | N/A | N/A | N/A | N/A |